NEW YORK, March 15, 2017 -- Dr. Wolf H. Stapelfeldt, Professor and Department Chairman at St. Louis University, has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise on Anesthesiology and Organ Transplantation.
In his current capacity as Tenured Professor and Department Chairman at St. Louis University since 2014, his day-to-day responsibilities include the oversight of the Anesthesia Department, researching and improving clinical outcomes while providing anesthesia services with an emphasis on minimizing harmful intraoperative hypotensive exposures. Dr. Stapelfeldt has authored over eighty-five academic research contributions with his research focused on liver transplantation and on creating predictive models, as well as developing electronic systems to allow physicians make better and more informed clinical decisions in real time at the various points of perioperative patient care.
He served as one of the Founders and as the original Chief Medical Officer of Talis Clinical, LLC, a Cleveland Clinic spinoff information management company. Talis Clinical has created software that distills and analyzes patient information in real time to guide physicians in the high stress high acuity care environments of the ORs, PACUs and ICUs.
Following graduation with his medical degree summa cum laude from the University of Ulm School of Medicine in Germany in 1983, Dr. Stapelfeldt pursued a post-graduate residency in internal medicine at Klinikum Rechts der Isar in Munich, and a fellowship in physiology and a residency in anesthesiology at the Mayo Clinic in Rochester, Minnesota.
Prior to his role as Professor and Department Chairman at St. Louis University, Dr. Stapelfeldt has held a series of leadership positions and appointments including those of Chairman of the Department of General Anesthesiology at the Cleveland Clinic, Professor and Chairman of the Department of Anesthesiology at the University of Florida College of Medicine, Vice Chairman for Education at Mayo Clinic’s Department of Anesthesiology in Florida, Director of Liver Transplant Anesthesiology and Director of Research for the Anesthesia Service at the VA Medical Center in Pittsburgh and Assistant Professor of Anesthesiology at the University of Pittsburgh Medical Center (UPMC). Additionally, he served as the Assistant Professor of Anesthesiology and Physiology at Mayo Clinic in Rochester, Minnesota.
As a testament to his success, Dr. Stapelfeldt’s contributions over the course of his career have been recognized with a ‘Top Ten in Medicine’ Innovations Award at the Cleveland Clinic, a U.S. Department of Veterans Affairs Merit Review award, a Young Investigator Award from the Foundation for Anesthesia Education and Research (FAER) and Roche Laboratories as well as Resident of the Year and Edward C. Kendall Awards from the Mayo Clinic.
Garnering over three decades of medical expertise, Dr. Stapelfeldt owns several patents and trademarks related to Clinical Decision Support technologies and is the creator of the SLUScore™ perioperative risk scoring concept. Additionally, he has provided seminal assistance in the establishment of liver transplant anesthesia programs at the Mayo Clinics in Jacksonville, Florida, and in Phoenix/Scottsdale, Arizona, as well as at the Children’s’ Hospital in San José, Costa Rica.
Looking back, Dr. Stapelfeldt attributes his success to being a part of great health care organizations and working in wonderful departments. His desire to pursue a career in Anesthesiology developed from his love for real time physiology and pharmacology.
To further his professional development, Dr. Stapelfeldt maintains memberships with the American Society of Anesthesiologists (ASA), the International Anesthesia Research Society (IARS), and the Healthcare Information and Management Systems Society (HIMSS).
As a certified single-engine pilot, Dr. Stapelfeldt enjoys flying sport planes in his free time. Other activities include his active engagement in animal rescue.
Considering the future, Dr. Stapelfeldt hopes and strives for the widespread realization of a substantial reduction in the significant postoperative morbidity and mortality that commonly ensues in the days, weeks and months following surgery and anesthesia.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



